| __timestamp | Catalent, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 334800000 | 504755000 |
| Thursday, January 1, 2015 | 337300000 | 838526000 |
| Friday, January 1, 2016 | 358100000 | 1177697000 |
| Sunday, January 1, 2017 | 402600000 | 1320433000 |
| Monday, January 1, 2018 | 462600000 | 1556200000 |
| Tuesday, January 1, 2019 | 512000000 | 1834800000 |
| Wednesday, January 1, 2020 | 577900000 | 1346000000 |
| Friday, January 1, 2021 | 687000000 | 1824900000 |
| Saturday, January 1, 2022 | 844000000 | 2115900000 |
| Sunday, January 1, 2023 | 831000000 | 2631300000 |
| Monday, January 1, 2024 | 935000000 | 2954400000 |
Data in motion
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Regeneron Pharmaceuticals and Catalent have shown distinct trends in their SG&A management. From 2014 to 2023, Regeneron's SG&A expenses have surged by approximately 420%, peaking in 2023. In contrast, Catalent's expenses have increased by about 180% over the same period. This suggests that while both companies are expanding, Regeneron's growth in SG&A costs is more pronounced. Notably, Catalent's expenses remained relatively stable until 2018, after which they saw a sharper increase. The data for 2024 is incomplete, highlighting the need for ongoing analysis. Understanding these trends can provide insights into each company's strategic priorities and operational efficiencies.
Bristol-Myers Squibb Company or Catalent, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Evotec SE
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Catalent, Inc. or Perrigo Company plc